Table 2.
Time to event comparison between the combined reduced and full dose DOACs.
| Events (%/yr) |
Reduced dose DOACs combined group rate per person-yeara (n = 514) | Full dose DOACs combined group rate per person-yeara (n = 199) | p-value univariable (from log rank test with Kaplan-Meier curve) | Proportional hazards multivariable hazard ratio: Low dose as reference (95 % CI)* | p-value from proportional hazards multivariable model* |
|---|---|---|---|---|---|
| SSE | 1.02 | 0 | 0.035 | N/A b | N/A b |
| CNS bleeding | 1.45 | 0.44 | 0.109 | 0.291 (0.054 to 1.56) |
0.204 |
| Non-CNS bleeding | 10.89 | 4.15 | < 0.001 | 0.72 (0.395 to 1.312) |
0.249 |
| All-cause mortality | 6.24 | 1.75 | < 0.001 | 0.338 (0.142 to 0.807) |
0.013 |
SSE = Stroke and systemic embolization; CNS = central nervous system.
Rates per person-year may be interpreted as annual percentages.
Too few cases in one group for multivariable model.
p values and hazard ratio adjusted for multivariable baseline differences.